Status:
COMPLETED
Hospital Based Group Intervention for Breast Cancer Patients.
Lead Sponsor:
Ullevaal University Hospital
Collaborating Sponsors:
The Royal Norwegian Ministry of Health
Conditions:
Breast Cancer
Anxiety
Eligibility:
FEMALE
18-74 years
Phase:
NA
Brief Summary
INCAM-study is a multicenter, prospective, randomized controlled trial. The aim of the study is to test the effectiveness of psychoeducative intervention when offered in hospital setting as a componen...
Detailed Description
Women operated for breast cancer often experience psychosocial problems for several years. Although, meta-analyses have clearly demonstrated that the efficacy of psychosocial support groups, little is...
Eligibility Criteria
Inclusion
- Verified breast cancer diagnosis Age 18 years or more but under 75 years -
Exclusion
- Diagnoses of metastatic breast cancer Do not read or write Norwegian Diagnoses of mental retardation, severe or untreated psychopathology, dementia Diagnoses of any immunologic condition or disease
- \-
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00289432
Start Date
April 1 2006
End Date
December 1 2014
Last Update
April 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ullevaal University Hospital
Oslo, Oslo County, Norway, 0407